Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
about
Viro-immune therapy: A new strategy for treatment of pancreatic cancerEngineering mesenchymal stem cells for regenerative medicine and drug deliveryMesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.Identification and characterization of unique tumoricidal genes in rat umbilical cord matrix stem cells.Influence of mesenchymal stem cells on metastasis development in mice in vivoPML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.Immunological applications of stem cells in type 1 diabetes.Polyethylenimine600-β-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cellsHuman mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in MacrophagesTargeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapyMultipotent mesenchymal stromal cell therapy and risk of malignancies.Oncolytic virotherapyTargeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells.The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils.Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer.Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle.Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.Stem cells in cancer therapy: opportunities and challenges.Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.The Critical, Clinical Role of Interferon-Beta in Regulating Cancer Stem Cell Properties in Triple-Negative Breast Cancer.MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
P2860
Q26774641-00B10923-62E1-4D1B-8695-D770A2595FD5Q27026414-FB7E0BE5-A853-41DB-AB5D-B5C567CAE8AEQ34402072-84E8A64F-E4DC-4D07-B269-4E75C53341D8Q35456178-607FB050-C3D5-4D58-AA59-EEE60CA4A302Q35556013-EB96A682-1C5F-4833-A591-68D0423D1CA2Q36187706-C0005DCD-4959-487C-8E0E-ED76111458BCQ36471345-71EC92CB-3FD0-459E-8ABA-2BA16EAF0D0CQ36666422-1DA6439C-39CF-4FCA-B1AA-041F3B7DD8B3Q36891378-12D32972-BF8D-4875-AD79-FCECA13586E3Q37050899-8A74E1C3-C6DE-4498-B0D6-6B986528E585Q37335524-263F0F94-42DD-4DCB-9315-02D728760D56Q37708056-520D0FB7-4CA7-4269-85F4-72390A54BBC8Q37975113-E572D616-30E3-4C3C-856E-6AB165103757Q38025263-FD6C95EE-5467-4718-B226-F69321F6512BQ38895289-975FD729-6418-42CD-ABE3-EEDFA9C11A1CQ38925583-BDCC638B-6506-46E5-8070-D1EBC959C5D3Q39076005-B84BACA0-447A-4068-8E47-3EB4923ADE0AQ39339902-24E6ACD1-E75D-4CB1-9878-235CCF00303BQ39863924-E90A8D96-CDC7-427B-B3B1-76164F85DDB4Q41586384-9506C4A4-911D-44AE-9B49-25B70A030BC1Q44577463-0E30A992-BD6A-48AB-91C8-C312ABF4FDB8Q47142453-13825984-1376-4A23-905A-1BD2BCD09EB8Q47304779-F579092B-A4FE-456F-A86F-1B5929B576D9Q51021313-8A8E5D2C-2055-497B-9EB9-1236994718F2Q52608756-E9EBD547-8BE2-469B-82E7-BDC616CB424DQ52653312-A2740045-5280-47D4-AAB1-D1C9FB0CA820Q53683974-EDE61C87-73A5-4BA6-BA25-CDF5D9BFE100Q57293797-651DEADE-23EC-4B22-ABAD-10C4ECB9E05F
P2860
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@ast
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@en
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@nl
type
label
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@ast
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@en
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@nl
prefLabel
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@ast
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@en
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@nl
P2093
P2860
P1433
P1476
Mesenchymal Stem Cells Overexp ...... ing in a Syngeneic Tumor Model
@en
P2093
Frank Marini
Jared Burks
Karen Clise-Dwyer
Lisa Caldwell
Rui-Yu Wang
Weiguo Zhang
Wendy Schober
Xiaoqing Yuan
Xiaoyang Ling
P2860
P2888
P356
10.1007/S12307-010-0041-8
P577
2010-03-19T00:00:00Z
P5875
P6179
1030433395